Function
Locations
Reduce fatty acyl-CoA to the fatty alcohol ether-chain donor.
Ether phospholipids, and especially the plasmalogens (1-O-alk-1'-enyl-2-acyl glycerophospholipids), are major membrane lipids - abundant in brain, heart and immune cells - that serve in membrane structure, vesicular trafficking, signalling and as endogenous antioxidants. Unlike ester glycerolipids their synthesis begins in the peroxisome. Fatty acyl-CoA reductase (FAR1, the rate-limiting and plasmalogen-feedback- regulated isoform; FAR2 a paralog) reduces long-chain fatty acyl-CoA to the fatty alcohol that will form the ether-linked sn-1 chain. In parallel, glyceronephosphate O-acyltransferase (GNPAT/DHAPAT) acylates dihydroxyacetone phosphate (DHAP) to acyl-DHAP - the first committed step. Alkyldihydroxyacetone-phosphate synthase (AGPS), an FAD enzyme that forms a complex with GNPAT, then exchanges the acyl group of acyl-DHAP for the FAR-derived fatty alcohol, creating the defining O-alkyl ether bond and yielding alkyl-DHAP. After further steps (reduction to alkyl-glycerol-3-phosphate, acylation, and headgroup addition, largely at the ER) the resulting plasmanylethanolamine is converted to the vinyl-ether plasmalogen plasmenylethanolamine by the ER desaturase PEDS1 (plasmanylethanolamine desaturase, formerly TMEM189), which introduces the characteristic 1-O-alk-1'-enyl double bond. Loss-of-function across the peroxisomal steps causes rhizomelic chondrodysplasia punctata (PEX7/RCDP1, GNPAT/RCDP2, AGPS/RCDP3, FAR1/RCDP4) and related plasmalogen- deficiency disorders.
All recommended fields populated.
✗ none found
No MODULE:ether_lipid_plasmalogen_biosynthesis deep-research report alongside the module YAML.
✓ every leaf node grounds to a representative protein.
✓ every declared conforms_to bundle matches its template motif.
✓ every PRECEDES step chains, or its break is acknowledged via chaining_status.
5 complete review(s) · 0 with deep research · 0 missing review · 5 reviewed but lacking deep research
| Gene | Review | Complete | Deep research |
|---|---|---|---|
| AGPS O00116 | ✓ | ✓ | ✗ |
| FAR1 Q8WVX9 | ✓ | ✓ | ✗ |
| FAR2 Q96K12 | ✓ | ✓ | ✗ |
| GNPAT O15228 | ✓ | ✓ | ✗ |
| PEDS1 A5PLL7 | ✓ | ✓ | ✗ |
Ether lipid / plasmalogen biosynthesis (GO:0008611), grounded to five completed human gene reviews. The peroxisomal ether-bond-forming module plus the ER plasmalogen-defining desaturation: FAR1 (Q8WVX9, rate- limiting, plasmalogen-feedback-regulated) / FAR2 (Q96K12, paralog), both PTHR11011, GO:0102965, reduce acyl-CoA -> fatty alcohol at the peroxisomal membrane; GNPAT/DHAPAT (O15228 PTHR12563, GO:0016287) acylates DHAP -> acyl-DHAP (first committed step); AGPS (O00116 PTHR46568, GO:0008609, FAD) exchanges the acyl for the FAR fatty alcohol -> alkyl-DHAP (committed ether-bond step; GNPAT-AGPS complex, peroxisomal matrix); after ER steps (not modelled here) PEDS1/TMEM189 (A5PLL7 PTHR48177, GO:0050207) introduces the vinyl-ether double bond -> plasmenylethanolamine. Curation: FAR1/FAR2 very-long-chain (GO:0080019) MF is a chain-length over-annotation (they prefer C16/C18, hence GO:0102965); GNPAT cytosol TAS = transient PTS1 pre-import cargo (non-core); AGPS mitochondrion HDA = peroxisome co-fractionation contaminant. Diseases: rhizomelic chondrodysplasia punctata - PEX7/RCDP1, GNPAT/RCDP2, AGPS/RCDP3, FAR1/RCDP4. GO term ids/labels verified against the local go.db; module passes structural + term-label validation.
Reduce fatty acyl-CoA to the fatty alcohol ether-chain donor.
Acylate DHAP to acyl-DHAP.
Form the O-alkyl ether bond, yielding alkyl-DHAP.
Introduce the 1-O-alk-1'-enyl (vinyl-ether) bond, making the plasmalogen.